ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SEER Seer Inc

1.78
-0.03 (-1.66%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Seer Inc NASDAQ:SEER NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.03 -1.66% 1.78 1.61 4.71 1.84 1.74 1.82 421,948 05:00:09

Seer to Report Third Quarter 2023 Financial Results on November 7, 2023

19/10/2023 9:05pm

GlobeNewswire Inc.


Seer (NASDAQ:SEER)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Seer Charts.

Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the third quarter of 2023 after market close on Tuesday, November 7, 2023. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.

About SeerSeer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor ContactCarrie Mendivilinvestor@seer.bio

Media ContactKaren Possemato pr@seer.bio 

1 Year Seer Chart

1 Year Seer Chart

1 Month Seer Chart

1 Month Seer Chart